Cerebral amyloid angiopathy with focal presentation-about 3 cases.
Alzheimer disease
Cerebral amyloid angiopathy
Focal cerebral amyloid angiopathy
Susceptibility-weighted imaging
Journal
Neuroradiology
ISSN: 1432-1920
Titre abrégé: Neuroradiology
Pays: Germany
ID NLM: 1302751
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
14
03
2020
accepted:
28
04
2020
pubmed:
18
5
2020
medline:
28
4
2021
entrez:
17
5
2020
Statut:
ppublish
Résumé
Cerebral amyloid angiopathy (CAA) is a common cerebrovascular disease involved in ischemic and hemorrhagic strokes, and its progression is correlated to cognitive decline. In vivo diagnosis of CAA is guided by the modified Boston criteria, with the presence of multiple intracerebral hemorrhage or cerebral microbleeds (CMB), or single hemorrhage and cortical superficial siderosis. The diagnosis of CAA is highly dependent on the quality of imaging and the advent of susceptibility-weighted imaging (SWI) sequences has improved sensitivity of MRI to detect hemosiderin deposition and CMB, hallmarks of CAA. We report here 3 clinical cases of patients with Alzheimer's disease and a focal form (i.e., not disseminated) of probable CAA, diagnosed with SWI sequences. Focal CAA may require closer attention and could offer keys in the understanding of both Alzheimer's disease and CAA pathogenesis.
Identifiants
pubmed: 32415390
doi: 10.1007/s00234-020-02450-8
pii: 10.1007/s00234-020-02450-8
doi:
Substances chimiques
Biomarkers
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM